Viridian Therapeutics, Inc.\DE (VRDN) Current Assets (2016 - 2025)
Historic Current Assets for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to $571.9 million.
- Viridian Therapeutics, Inc.\DE's Current Assets fell 2546.98% to $571.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $571.9 million, marking a year-over-year decrease of 2546.98%. This contributed to the annual value of $738.5 million for FY2024, which is 5179.74% up from last year.
- As of Q3 2025, Viridian Therapeutics, Inc.\DE's Current Assets stood at $571.9 million, which was down 2546.98% from $578.8 million recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Current Assets ranged from a high of $767.4 million in Q3 2024 and a low of $115.5 million during Q2 2021
- Its 5-year average for Current Assets is $417.4 million, with a median of $431.2 million in 2022.
- Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Current Assets skyrocketed by 58165.9% in 2021 and then plummeted by 2595.51% in 2023.
- Viridian Therapeutics, Inc.\DE's Current Assets (Quarter) stood at $200.2 million in 2021, then skyrocketed by 115.41% to $431.2 million in 2022, then grew by 12.83% to $486.5 million in 2023, then surged by 51.8% to $738.5 million in 2024, then decreased by 22.55% to $571.9 million in 2025.
- Its Current Assets was $571.9 million in Q3 2025, compared to $578.8 million in Q2 2025 and $657.2 million in Q1 2025.